; or (B) containing any active pharmaceutical ingredient or excipient that was manufactured in a covered country. . (b) Report to Congress Not later than 3 years after the date of enactment of this Act, the Secretary of Health and Human Services shall submit to the Congress a report on the Abraham Accords Bureau, including— (1) an evaluation of— (A) how each office of the Bureau has advanced progress toward shifting United States supply chains of essential medical products from covered countries to Abraham Accords countries (as such terms are defined in section 1015 of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a)); and (B) the effectiveness of the activities carried out pursuant to section 1015(c) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a); and (2) recommendations for increasing and improving coordination between the Food and Drug Administration and entities in Abraham Accords countries (as such term is defined in section 1015 of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a)).